TrueCold and Grasshopper Air Mobility Join Forces at SIL 2025 to Transform Pharma Cold Chain Logistics

Barcelona, Spain — At this year’s SIL 2025, TrueCold and Grasshopper Air Mobility announced a new partnership aimed at redefining how temperature-sensitive pharmaceuticals are transported. The two Barcelona-based innovators have signed a Memorandum of Understanding (MoU) to collaborate on the development of cutting-edge logistics solutions that merge aerial mobility with advanced cold chain intelligence.

Through this collaboration, Grasshopper Air Mobility becomes the first heavy cargo drone operator to integrate a pharma-validated cold chain monitoring platform, ensuring precise control and full traceability of critical medical shipments.

For TrueCold, this agreement marks a milestone in extending its technology beyond traditional ground logistics — applying its real-time monitoring and AI-driven compliance tools to aerial delivery systems. Together, the companies are setting new standards for safety, reliability, and efficiency in global pharma logistics.

Both organizations are part of the Logistics 4.0 Incubator of the Consortium of the Zona Franca Barcelona, a hub fostering collaboration among startups and innovators in supply chain technology. This alliance is a direct outcome of that ecosystem’s vision — where mobility and data converge to power the next generation of sustainable logistics.

About Grasshopper Air Mobility

Grasshopper Air Mobility designs and manufactures heavy cargo drones that bring efficiency and flexibility to logistics operations. Headquartered in Barcelona, the company’s mission is to make aerial logistics accessible for businesses of all sizes through advanced air mobility solutions.
🔗 www.grasshopperairmobility.com